{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:43:49Z","timestamp":1793839429237,"version":"4.6.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>\n            Preeclampsia is a multifactorial hypertensive disorder of pregnancy, with variable presentation in both maternal and fetal factors, such that no treatment or marker is currently universal to all cases. Here, we demonstrate that the prothrombinase and immunomodulatory secreted factor FGL-2 (fibrinogen-like protein 2) is differentially expressed across previously characterized gene expression clusters containing clinically relevant disease subtypes.\n            <jats:italic>FGL2<\/jats:italic>\n            is low in a cluster consistent with the traditional paradigm of the pathology of preeclampsia (canonical preeclampsia) and high in a cluster exhibiting evidence of immune activation (immunological preeclampsia). We show that it is part of an immunoregulatory gene module integral to the transcriptional profile and placental pathology specific to immunological preeclampsia. We determine that\n            <jats:italic>FGL2<\/jats:italic>\n            associates positively with chronic inflammation lesions of the placenta while associating negatively with maternal vascular malperfusion lesions. The transcriptional profiles of maternal vascular malperfusion lesions show downregulation of\n            <jats:italic>FGL2<\/jats:italic>\n            and upregulation of previously investigated preeclampsia biomarkers, such as FLT1 (Fms Related Receptor Tyrosine Kinase 1) and ENG (endoglin). Conversely, the profiles of chronic inflammation lesions show an interesting downregulation of these genes, but an upregulation of\n            <jats:italic>FGL2<\/jats:italic>\n            and of\n            <jats:italic>FGL2<\/jats:italic>\n            -correlated immunoregulatory genes, suggesting it is upregulated downstream of major inflammatory mediators such as TNF (tumor necrosis factor)-\u03b1 and IFN (interferon)-\u03b3, hallmarks of the immunological preeclampsia subtype. This work, overall, demonstrates that FGL-2 expression levels in the term placenta reflect the unique pathophysiology that leads to immunological preeclampsia, leading to its potential as a subtype-specific biomarker.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.14807","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T09:00:36Z","timestamp":1595840436000},"page":"910-921","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Fibrinogen-Like Protein 2-Associated Transcriptional and Histopathological Features of Immunological Preeclampsia"],"prefix":"10.1161","volume":"76","author":[{"given":"Pascale","family":"Robineau-Charette","sequence":"first","affiliation":[{"name":"From the Department of Cellular and Molecular Medicine (P.R.-C., S.J.B, B.C.V., S.A.B.), University of Ottawa, ON, Canada"},{"name":"Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada (P.R.-C., B.C.V.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grynspan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine (D.G.), University of Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Benton","sequence":"additional","affiliation":[{"name":"From the Department of Cellular and Molecular Medicine (P.R.-C., S.J.B, B.C.V., S.A.B.), University of Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Gaudet","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Interdisciplinary School of Health Sciences, Faculty of Health Sciences (J.G., S.A.B.), University of Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Cox","sequence":"additional","affiliation":[{"name":"Department of Physiology (B.J.C.), Faculty of Medicine, University of Toronto, ON, Canada."},{"name":"Department of Obstetrics and Gynecology (B.J.C.), Faculty of Medicine, University of Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Vanderhyden","sequence":"additional","affiliation":[{"name":"From the Department of Cellular and Molecular Medicine (P.R.-C., S.J.B, B.C.V., S.A.B.), University of Ottawa, ON, Canada"},{"name":"Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada (P.R.-C., B.C.V.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8947-8152","authenticated-orcid":true,"given":"Shannon A.","family":"Bainbridge","sequence":"additional","affiliation":[{"name":"From the Department of Cellular and Molecular Medicine (P.R.-C., S.J.B, B.C.V., S.A.B.), University of Ottawa, ON, Canada"},{"name":"Faculty of Medicine and Interdisciplinary School of Health Sciences, Faculty of Health Sciences (J.G., S.A.B.), University of Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","first-page":"1","volume-title":"Hypertension in Pregnancy","author":"Task Force on Hypertension in Pregnancy","year":"2014","unstructured":"Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Washington, DC. Congress LO; 2014:1\u2013100."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2011.01.005"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00250"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116508"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07293"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.09.036"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.1.249"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0897.2001.d01-3.x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13696"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1528"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2014.956360"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw199"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113503406"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-018-0681-y"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03979"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.01.126"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2011.01823.x"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000250831.52876.cb"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(99)70448-5"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.05.056"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2014.10.004"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031884"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2014.10.003"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.05.025"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/apm.12796"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.07.002"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199011000-00014"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133738"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12143"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.01.017"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2010.536163"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.09.051"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.14807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:46:20Z","timestamp":1715597180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.14807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.14807"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.14807","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-01-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}